MedTrace Logo

Investigating Mucinase Activity in Airway Disease

NCT00596232 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 211

Last updated 2016-05-02

No results posted yet for this study

Summary

The purpose of this study is to investigate how mucus (phlegm or spit) is broken down once it forms in the airways (bronchial tubes) of people with lung disease. This research study will also examine whether blood groups have an effect on lung function or the type of mucus found in the lung. This study is not designed to be a treatment for asthma, emphysema, cystic fibrosis, or other lung disease. It is designed to help the investigators learn more about the causes of airway disease.

Conditions

Sponsors & Collaborators

Principal Investigators

  • John V Fahy, M.D., M.Sc. · University of California, San Francisco

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-04-30
Primary Completion
2015-12-31
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00596232 on ClinicalTrials.gov